BeOne Medicines (BEIGF) Construction in Progress (2016 - 2026)

BeOne Medicines (BEIGF) has 10 years of Construction in Progress data on file, last reported at $137.4 million in Q1 2026.

• Construction in Progress for Q1 2026 came in at $137.4 million, down 76.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $137.4 million (down 76.7% YoY), and the FY2025 annual result was $127.2 million, down 80.56% from the prior year.
• Construction in Progress rose to $137.4 million in Q1 2026 per BEIGF's latest filing, from $127.2 million in the prior quarter.
• Over five years, Construction in Progress peaked at $863.4 million in Q2 2024 and troughed at $127.2 million in Q4 2025.
• A 5-year average of $447.9 million and a median of $430.6 million in 2023 frame the typical range for Construction in Progress.
• The sharpest annual moves came in 2023 and 2025: Construction in Progress jumped 184.02% in 2023, then tumbled 80.56% in 2025.
• A 5-year view of Construction in Progress shows it stood at $293.6 million in 2022, then jumped by 152.23% to $740.6 million in 2023, then fell by 11.69% to $654.0 million in 2024, then plunged by 80.56% to $127.2 million in 2025, then grew by 8.09% to $137.4 million in 2026.
• Business Quant data shows BEIGF's Construction in Progress at $137.4 million in Q1 2026, $127.2 million in Q4 2025, and $129.1 million in Q3 2025.